Sign in
4

Changes in Ownership

Acrivon Therapeutics, Inc. Filed Acc 0000905148-25-002170

Options or other derivatives

  • Director acquired 20,275 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

BAUM CHARLES M · Director

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2025-06-13 Grant or award : show line 1 in the form Stock Option (Right to Buy) +20,275 20,275 D
Loading xslF345X05/form4.xml…